Amgen To Present At The Morgan Stanley Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Baird 'Incrementally Positive' on Amgen's (AMGN) Initial AMG 420 results
September 10, 2018 12:01 PM EDTBaird analyst Brian Skorney is incrementally positive on Amgen's (NASDAQ: AMGN) initial AMG 420 results.
"We think the very first clinical results for Amgen's anti-BCMA BiTE look very promising and competitive with those of the CART approach (CELG/BLUE/JNJ)," Skorney said. "We... More
